Voyager Therapeutics Inc [VYGR] stock prices are up 18.69% to $6.86 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The VYGR shares have gain 26.34% over the last week, with a monthly amount glided 0.29%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Leerink Partners started tracking the stock with Outperform rating on October 16, 2024, and set its price target to $15. On March 26, 2024, Guggenheim initiated with a Buy rating and assigned a price target of $22 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $30 on March 19, 2024. Citigroup initiated its recommendation with a Buy and recommended $16 as its price target on March 07, 2024. Wells Fargo upgraded its rating to Overweight for this stock on January 02, 2024, but kept the price target unchanged to $14. In a note dated May 10, 2023, Truist initiated an Buy rating and provided a target price of $18 on this stock.
The stock price of Voyager Therapeutics Inc [VYGR] has been fluctuating between $5.19 and $11.72 over the past year. Currently, Wall Street analysts expect the stock to reach $15.2 within the next 12 months. Voyager Therapeutics Inc [NASDAQ: VYGR] shares were valued at $6.86 at the most recent close of the market. An investor can expect a potential return of 121.57% based on the average VYGR price forecast.
Analyzing the VYGR fundamentals
The Voyager Therapeutics Inc [NASDAQ:VYGR] reported sales of 163.78M for trailing twelve months, representing a surge of 433.79%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.08 and Total Capital is 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.41 points at the first support level, and at 5.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.17, and for the 2nd resistance point, it is at 7.48.
Ratios To Look Out For
It’s worth pointing out that Voyager Therapeutics Inc [NASDAQ:VYGR]’s Current Ratio is 8.45. On the other hand, the Quick Ratio is 8.45, and the Cash Ratio is 2.55. Considering the valuation of this stock, the price to sales ratio is 2.72, the price to book ratio is 1.13 and price to earnings (TTM) ratio is 9.52.
Transactions by insiders
Recent insider trading involved Fahey Sandell Jacquelyn, Chief Legal Officer, that happened on Oct 02 ’24 when 5999.0 shares were sold. Officer, Fahey Sandell Jacquelyn completed a deal on Oct 02 ’24 to buy 5999.0 shares. Meanwhile, Chief Operating Officer Swartz Robin sold 1357.0 shares on Apr 02 ’24.
